An Immersive Virtual Reality Curriculum for Pediatric Hematology Clinicians on Shared Decision-making for Hydroxyurea in Sickle Cell Anemia
- PMID: 35319512
- PMCID: PMC8943226
- DOI: 10.1097/MPH.0000000000002289
An Immersive Virtual Reality Curriculum for Pediatric Hematology Clinicians on Shared Decision-making for Hydroxyurea in Sickle Cell Anemia
Abstract
Although hydroxyurea (HU) is an effective treatment for sickle cell anemia, uptake remains low. Shared decision-making (SDM) is a recommended strategy for HU initiation to elicit family preferences; however, clinicians lack SDM training. We implemented an immersive virtual reality (VR) curriculum at 8 pediatric institutions to train clinicians on SDM that included counseling virtual patients. Clinicians' self-reported confidence significantly improved following the VR simulations on all communication skills assessed, including asking open-ended questions, eliciting specific concerns, and confirming understanding (Ps≤0.01 for all). VR may be an effective method for educating clinicians to engage in SDM for HU.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
The authors declare no conflict of interest.
Figures


Similar articles
-
Engaging Parents of Children With Sickle Cell Disease in Shared Decision-Making for Hydroxyurea: The ENGAGE-HU Study.Pediatr Blood Cancer. 2025 May;72(5):e31639. doi: 10.1002/pbc.31639. Epub 2025 Mar 6. Pediatr Blood Cancer. 2025. PMID: 40051208
-
The Role of Patient-Physician Communication on the Use of Hydroxyurea in Adult Patients with Sickle Cell Disease.J Racial Ethn Health Disparities. 2019 Dec;6(6):1233-1243. doi: 10.1007/s40615-019-00625-5. Epub 2019 Aug 13. J Racial Ethn Health Disparities. 2019. PMID: 31410784 Free PMC article.
-
Resident perspectives on communication training that utilizes immersive virtual reality.Educ Health (Abingdon). 2017 Sep-Dec;30(3):228-231. doi: 10.4103/efh.EfH_9_17. Educ Health (Abingdon). 2017. PMID: 29786025
-
Use of hydroxyurea in children with sickle cell disease: what comes next?Semin Hematol. 1997 Jul;34(3 Suppl 3):30-41. Semin Hematol. 1997. PMID: 9317199 Review.
-
Hydroxyurea therapy: improving the lives of patients with sickle cell disease.Pediatr Nurs. 2006 Nov-Dec;32(6):541-3. Pediatr Nurs. 2006. PMID: 17256291 Review.
Cited by
-
Using the consolidated framework for implementation research to identify recruitment barriers and targeted strategies for a shared decision-making randomized clinical trial in pediatric sickle cell disease.Clin Trials. 2023 Jun;20(3):211-222. doi: 10.1177/17407745231154199. Epub 2023 Feb 16. Clin Trials. 2023. PMID: 36794731 Free PMC article. Clinical Trial.
-
Psychologists as leaders in equitable science: Applications of antiracism and community participatory strategies in a pediatric behavioral medicine clinical trial.Am Psychol. 2023 Feb-Mar;78(2):107-118. doi: 10.1037/amp0001086. Am Psychol. 2023. PMID: 37011163 Free PMC article.
-
Feasibility and Acceptability of a Virtual Reality Curriculum to Support Firearm Safety Counseling Skills Among Pediatric Residents.J Grad Med Educ. 2024 Dec;16(6):740-746. doi: 10.4300/JGME-D-24-00022.1. Epub 2024 Dec 13. J Grad Med Educ. 2024. PMID: 39677314 Free PMC article.
-
Virtual Simulation Tools for Communication Skills Training in Health Care Professionals: Literature Review.JMIR Med Educ. 2025 May 6;11:e63082. doi: 10.2196/63082. JMIR Med Educ. 2025. PMID: 40327882 Free PMC article. Review.
-
Engaging Caregivers and Providers of Children With Sickle Cell Anemia in Shared Decision Making for Hydroxyurea: Protocol for a Multicenter Randomized Controlled Trial.JMIR Res Protoc. 2021 May 21;10(5):e27650. doi: 10.2196/27650. JMIR Res Protoc. 2021. PMID: 34018965 Free PMC article.
References
-
- Smith AW, Bodas P, Sidebotham L, et al. Improving Uptake of Hydroxyurea in Patients with Sickle Cell Disease: A Retrospective Study of a Clinic-based Change in Consenting Practices. J Natl Med Assoc. 2019;111(2):169–175. - PubMed
-
- Yawn BP, Buchanan GR, Afenyi-Annan AN, et al. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members. Jama. 2014;312(10):1033–1048. - PubMed